GlaxoSmithKline
An update on recent developments released by GlaxoSmithKline
Published in Managed Care Law Weekly, August 26th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at GlaxoSmithKline.
Report 1: GlaxoSmithKline announced positive data from three key studies on its first-in-class, oral small molecule HER2 kinase inhibitor, TYKERB(R) (lapatinib). Results of these and other important TYKERB studies are being presented this week at the 2007 American Society of Clinical Oncology (ASCO) annual meeting in Chicago, Illinois. The use of TYKERB in these settings is investigational.
"The robust clinical data presented for TYKERB at ASCO further...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Managed Care Law Weekly
More Articles from Managed Care Law Weekly
- A.M. Best Co.
A.M. Best Introduces Credit Rating Services for Hospitals and Health-Care Systems - Aarp
Seniors Set to be Hit Hard by Illinois Budget - Aetna
Aetna Chairman and CEO Adopts 10b5-1 Plan - Aetna
Edmund J. Pezalla, M.D., MPH Named National Medical Director for Aetna Pharmacy Management - American Imaging Management, Inc.
American Imaging Management Enters into Agreement with Blue Cross and Blue Shield of Florida - AmericaSpeaks
Thousands of Californians Gather Across the State to Help Lawmakers Shape Upcoming Plans for Health Care Reform - More from this issue of Managed Care Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
